| 2.4 |
7.1 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 2.0 |
6.0 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 1.1 |
1.1 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 1.1 |
4.6 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 1.1 |
6.5 |
GO:0003383 |
apical constriction(GO:0003383) |
| 1.0 |
3.0 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.9 |
2.8 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.9 |
2.7 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.9 |
4.3 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.8 |
2.5 |
GO:0042939 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.8 |
3.3 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.8 |
7.9 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.8 |
3.1 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.8 |
2.3 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.7 |
2.2 |
GO:0030421 |
defecation(GO:0030421) |
| 0.7 |
4.4 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.7 |
1.4 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.7 |
2.1 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.7 |
2.1 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.7 |
2.8 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.7 |
3.4 |
GO:1902965 |
protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.7 |
2.7 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.7 |
0.7 |
GO:0034727 |
lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
| 0.7 |
2.6 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.6 |
3.2 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.6 |
5.0 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.6 |
1.9 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.6 |
1.9 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.6 |
3.0 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.6 |
3.0 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.6 |
2.4 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.6 |
1.2 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.6 |
1.8 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.6 |
0.6 |
GO:0035878 |
nail development(GO:0035878) |
| 0.6 |
1.7 |
GO:1904395 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.6 |
2.9 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) |
| 0.6 |
4.6 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.6 |
1.1 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.6 |
1.7 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) |
| 0.6 |
3.4 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.6 |
2.8 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.6 |
2.2 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.6 |
4.4 |
GO:1902669 |
positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
| 0.6 |
3.9 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.5 |
1.1 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.5 |
2.7 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.5 |
1.6 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.5 |
1.6 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.5 |
0.5 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.5 |
2.1 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.5 |
0.5 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.5 |
2.0 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.5 |
2.0 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.5 |
2.0 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.5 |
1.5 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.5 |
2.0 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.5 |
2.5 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.5 |
1.5 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.5 |
1.5 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.5 |
0.5 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.5 |
1.9 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.5 |
1.9 |
GO:0072362 |
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 0.5 |
1.4 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.5 |
0.9 |
GO:0061344 |
regulation of cell adhesion involved in heart morphogenesis(GO:0061344) positive regulation of ephrin receptor signaling pathway(GO:1901189) |
| 0.5 |
1.4 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.5 |
1.4 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.5 |
0.5 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.5 |
0.5 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.5 |
2.7 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.5 |
5.0 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.5 |
0.5 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.4 |
2.7 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 0.4 |
0.4 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.4 |
0.4 |
GO:0031498 |
nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
| 0.4 |
1.7 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.4 |
0.4 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.4 |
1.7 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.4 |
1.7 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.4 |
1.7 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.4 |
0.4 |
GO:0003094 |
glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
| 0.4 |
1.3 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.4 |
2.1 |
GO:0034183 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 0.4 |
4.6 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.4 |
0.8 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.4 |
0.4 |
GO:1904173 |
regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
| 0.4 |
3.7 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 0.4 |
1.2 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.4 |
1.2 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.4 |
1.6 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 |
1.2 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.4 |
2.0 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.4 |
0.4 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.4 |
2.0 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.4 |
0.4 |
GO:0060948 |
cardiac vascular smooth muscle cell development(GO:0060948) |
| 0.4 |
2.0 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.4 |
0.8 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.4 |
0.8 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.4 |
0.8 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.4 |
2.7 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.4 |
1.2 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.4 |
0.8 |
GO:1902837 |
amino acid import into cell(GO:1902837) |
| 0.4 |
1.1 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.4 |
1.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.4 |
1.9 |
GO:0042977 |
activation of JAK2 kinase activity(GO:0042977) |
| 0.4 |
1.1 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.4 |
4.8 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.4 |
0.7 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.4 |
1.1 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.4 |
0.4 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.4 |
2.5 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.4 |
3.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.4 |
1.8 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.4 |
1.8 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.4 |
1.4 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.4 |
0.4 |
GO:1904884 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.4 |
2.1 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.3 |
0.3 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.3 |
1.0 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.3 |
1.0 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.3 |
1.7 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.3 |
0.7 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.3 |
0.7 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.3 |
1.7 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.3 |
4.1 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.3 |
1.3 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.3 |
0.7 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.3 |
1.3 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.3 |
1.0 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.3 |
2.9 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.3 |
1.9 |
GO:1904738 |
vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.3 |
0.3 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.3 |
1.3 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.3 |
0.6 |
GO:0060466 |
activation of meiosis involved in egg activation(GO:0060466) |
| 0.3 |
0.3 |
GO:0039519 |
modulation by virus of host autophagy(GO:0039519) |
| 0.3 |
0.9 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.3 |
0.3 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.3 |
1.2 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.3 |
0.9 |
GO:0033700 |
phospholipid efflux(GO:0033700) |
| 0.3 |
4.0 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.3 |
0.3 |
GO:0001907 |
killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.3 |
0.9 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.3 |
0.6 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.3 |
2.4 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.3 |
1.8 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.3 |
1.2 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.3 |
2.7 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.3 |
0.3 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.3 |
1.5 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.3 |
0.9 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.3 |
0.3 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.3 |
0.6 |
GO:0070344 |
fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 |
0.9 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.3 |
1.5 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.3 |
0.9 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.3 |
0.3 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.3 |
0.6 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.3 |
0.9 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.3 |
0.9 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.3 |
1.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.3 |
0.9 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.3 |
1.1 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 |
0.9 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.3 |
0.3 |
GO:0060032 |
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.3 |
1.1 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.3 |
0.8 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.3 |
3.9 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
| 0.3 |
0.8 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.3 |
0.5 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.3 |
1.1 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.3 |
0.8 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.3 |
1.1 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.3 |
1.3 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.3 |
2.1 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.3 |
1.1 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.3 |
0.8 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.3 |
0.5 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.3 |
0.5 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.3 |
0.3 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.3 |
2.9 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.3 |
1.8 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.3 |
0.5 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.3 |
3.1 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.3 |
1.5 |
GO:0031652 |
positive regulation of heat generation(GO:0031652) |
| 0.3 |
1.3 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.3 |
0.8 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.3 |
0.3 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.3 |
1.5 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.3 |
0.5 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.3 |
0.3 |
GO:0010878 |
cholesterol storage(GO:0010878) |
| 0.3 |
1.0 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.3 |
0.8 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.3 |
1.5 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.3 |
1.0 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.2 |
1.0 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 0.2 |
2.0 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 |
0.7 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.2 |
0.5 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.2 |
0.7 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.2 |
1.5 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.2 |
0.2 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
1.0 |
GO:0044332 |
Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.2 |
0.7 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 0.2 |
0.7 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.2 |
0.5 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.2 |
0.2 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.2 |
1.2 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
1.0 |
GO:0036302 |
atrioventricular canal development(GO:0036302) |
| 0.2 |
0.9 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.2 |
1.2 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.2 |
1.4 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.2 |
0.7 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.2 |
0.5 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) |
| 0.2 |
2.6 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.2 |
0.7 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.2 |
1.2 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.2 |
0.7 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.2 |
0.9 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.2 |
0.9 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.2 |
0.7 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 |
1.1 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.2 |
1.6 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 |
0.9 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.2 |
1.4 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.2 |
1.6 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.2 |
0.2 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.2 |
0.9 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.2 |
0.7 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.2 |
0.7 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 |
0.7 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.2 |
1.5 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 |
0.7 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.2 |
0.2 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.2 |
0.9 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.2 |
2.8 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.2 |
1.1 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.2 |
1.7 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.2 |
0.4 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.2 |
0.6 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.2 |
0.4 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 |
1.0 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.2 |
1.9 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 |
0.2 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 0.2 |
0.8 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.2 |
2.7 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.2 |
1.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 |
0.2 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.2 |
0.2 |
GO:0031297 |
replication fork processing(GO:0031297) DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.2 |
0.8 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.2 |
0.4 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.2 |
0.8 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 |
0.2 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.2 |
0.2 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.2 |
0.4 |
GO:0045349 |
interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.2 |
0.6 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.2 |
0.6 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
| 0.2 |
0.4 |
GO:0050655 |
dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.2 |
0.8 |
GO:0031650 |
regulation of heat generation(GO:0031650) |
| 0.2 |
0.4 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.2 |
3.8 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
0.2 |
GO:0061054 |
dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
| 0.2 |
2.0 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 |
0.2 |
GO:2000169 |
regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.2 |
1.6 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.2 |
0.8 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 |
1.0 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.2 |
1.4 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.2 |
0.2 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 |
1.9 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.2 |
0.6 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.2 |
0.8 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.2 |
0.8 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
0.6 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.2 |
0.2 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) |
| 0.2 |
0.2 |
GO:2000121 |
regulation of superoxide dismutase activity(GO:1901668) regulation of removal of superoxide radicals(GO:2000121) |
| 0.2 |
0.6 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) |
| 0.2 |
0.4 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.2 |
0.7 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.2 |
1.7 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.2 |
0.7 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 |
0.5 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.2 |
0.9 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.2 |
4.6 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.2 |
0.5 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.2 |
0.2 |
GO:0048382 |
mesendoderm development(GO:0048382) |
| 0.2 |
0.5 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.2 |
1.1 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.2 |
0.5 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.2 |
1.2 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.2 |
0.5 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.2 |
0.7 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.2 |
0.5 |
GO:0030220 |
platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.2 |
1.6 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
1.1 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 |
1.1 |
GO:0039535 |
regulation of RIG-I signaling pathway(GO:0039535) |
| 0.2 |
0.5 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.2 |
0.5 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.2 |
1.1 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.2 |
0.5 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 |
1.8 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
1.2 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
0.5 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.2 |
0.5 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.2 |
0.3 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.2 |
0.3 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.2 |
1.4 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.2 |
1.7 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.2 |
0.7 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.2 |
0.9 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 |
2.1 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.2 |
0.5 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.2 |
0.2 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.2 |
3.9 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 |
0.2 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.2 |
0.5 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.2 |
0.5 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.2 |
5.0 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.2 |
0.2 |
GO:0032474 |
otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
| 0.2 |
0.2 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.2 |
0.8 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
0.3 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.2 |
1.1 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.2 |
0.2 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.2 |
0.2 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.2 |
1.3 |
GO:0003413 |
chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.2 |
0.3 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
0.6 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 |
1.3 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.2 |
1.4 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.2 |
0.9 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 |
0.6 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 |
0.2 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.2 |
0.6 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.2 |
0.8 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.2 |
0.2 |
GO:0060677 |
ureteric bud elongation(GO:0060677) |
| 0.2 |
0.2 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.2 |
0.8 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 |
0.5 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.2 |
0.2 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.2 |
0.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.2 |
1.5 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.2 |
0.5 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
1.4 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 |
0.3 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.2 |
0.2 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.2 |
1.1 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 |
0.3 |
GO:1902566 |
regulation of eosinophil activation(GO:1902566) |
| 0.2 |
1.2 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 |
0.5 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.2 |
1.4 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 |
0.2 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.1 |
0.3 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.1 |
0.3 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.1 |
0.9 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.1 |
2.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.4 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) |
| 0.1 |
0.4 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.1 |
1.0 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
1.5 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.7 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.1 |
0.6 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.1 |
1.2 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 |
1.0 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.4 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.1 |
1.4 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.1 |
1.9 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.3 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.1 |
0.3 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.1 |
0.4 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.1 |
1.0 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
1.3 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.1 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
| 0.1 |
2.6 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.1 |
1.7 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.1 |
0.6 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.1 |
0.1 |
GO:0051176 |
positive regulation of sulfur metabolic process(GO:0051176) |
| 0.1 |
0.3 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.1 |
0.3 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
2.6 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.1 |
0.5 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.1 |
0.1 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.1 |
0.8 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
0.3 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.1 |
0.8 |
GO:0003283 |
atrial septum development(GO:0003283) |
| 0.1 |
0.4 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.1 |
1.8 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
| 0.1 |
0.3 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
1.1 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 |
0.4 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.1 |
1.3 |
GO:0090179 |
planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.1 |
0.7 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
4.0 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 |
2.0 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.1 |
0.7 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
0.4 |
GO:0035826 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
0.5 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 |
1.2 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.9 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.6 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
0.4 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.1 |
0.8 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.1 |
0.5 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.1 |
0.4 |
GO:1903441 |
protein localization to ciliary membrane(GO:1903441) |
| 0.1 |
0.4 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 |
0.4 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.1 |
0.8 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.1 |
1.0 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.1 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.1 |
0.3 |
GO:1900426 |
positive regulation of defense response to bacterium(GO:1900426) |
| 0.1 |
0.5 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.1 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.1 |
0.3 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
1.1 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 |
2.7 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.1 |
0.6 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.1 |
0.4 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
1.3 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.1 |
0.1 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 |
4.3 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.1 |
0.4 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
0.1 |
GO:0032632 |
interleukin-3 production(GO:0032632) |
| 0.1 |
1.9 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.2 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.1 |
0.6 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
1.1 |
GO:0006691 |
leukotriene metabolic process(GO:0006691) |
| 0.1 |
0.4 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.1 |
GO:2000425 |
regulation of apoptotic cell clearance(GO:2000425) |
| 0.1 |
0.1 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.1 |
2.0 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.1 |
0.4 |
GO:0051462 |
cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
| 0.1 |
0.1 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) |
| 0.1 |
0.4 |
GO:0000467 |
exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
| 0.1 |
0.7 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.1 |
0.5 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.1 |
0.2 |
GO:0035019 |
somatic stem cell population maintenance(GO:0035019) |
| 0.1 |
0.8 |
GO:0003323 |
type B pancreatic cell development(GO:0003323) |
| 0.1 |
0.2 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.1 |
0.5 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 |
0.7 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.3 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.1 |
0.2 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
1.3 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.1 |
0.5 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 |
0.3 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.1 |
0.2 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.1 |
0.6 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.3 |
GO:0002327 |
immature B cell differentiation(GO:0002327) |
| 0.1 |
0.3 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.1 |
0.3 |
GO:0002716 |
negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.1 |
0.2 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.1 |
0.6 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
0.9 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.3 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.1 |
1.2 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.1 |
0.4 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
0.7 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 |
0.3 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.1 |
0.6 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.8 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.1 |
0.1 |
GO:0006278 |
RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) telomere maintenance via telomere lengthening(GO:0010833) |
| 0.1 |
0.5 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.1 |
0.3 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.7 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 |
0.7 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.4 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.1 |
0.7 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.1 |
0.1 |
GO:0060442 |
branching involved in prostate gland morphogenesis(GO:0060442) |
| 0.1 |
0.4 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.1 |
0.6 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.6 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.4 |
GO:0009445 |
putrescine metabolic process(GO:0009445) |
| 0.1 |
0.3 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.2 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.1 |
0.2 |
GO:0071732 |
cellular response to nitric oxide(GO:0071732) |
| 0.1 |
0.4 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.1 |
1.4 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
0.1 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.1 |
0.2 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.1 |
0.3 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.1 |
0.4 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.1 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.1 |
2.4 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
0.4 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 |
2.0 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.2 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
0.3 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.7 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.1 |
1.7 |
GO:0014887 |
cardiac muscle adaptation(GO:0014887) |
| 0.1 |
0.1 |
GO:0048302 |
isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.1 |
0.3 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
1.0 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 |
0.5 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.6 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 |
0.4 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.1 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
0.5 |
GO:1903147 |
negative regulation of mitophagy(GO:1903147) |
| 0.1 |
0.5 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.1 |
0.7 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
0.5 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
0.4 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.1 |
0.5 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.1 |
0.2 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
0.5 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.3 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
0.3 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
0.3 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 |
0.3 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 |
0.1 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.1 |
0.3 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.1 |
0.6 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
5.9 |
GO:0045995 |
regulation of embryonic development(GO:0045995) |
| 0.1 |
0.1 |
GO:0035743 |
T cell cytokine production(GO:0002369) CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 |
0.2 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.1 |
0.3 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.5 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.1 |
0.4 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.5 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
1.6 |
GO:0046460 |
triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.1 |
1.3 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.1 |
0.8 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 |
0.3 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.6 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.4 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 |
0.1 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.1 |
0.3 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 |
0.3 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 |
0.6 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.6 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.1 |
0.1 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
0.1 |
GO:0032415 |
regulation of sodium:proton antiporter activity(GO:0032415) |
| 0.1 |
0.3 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 |
0.8 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
1.1 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.2 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.1 |
0.5 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.1 |
0.7 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
3.5 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.1 |
1.0 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.3 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.1 |
1.2 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.1 |
0.4 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.1 |
0.2 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.1 |
0.1 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.1 |
0.4 |
GO:0042304 |
regulation of fatty acid biosynthetic process(GO:0042304) |
| 0.1 |
0.2 |
GO:1905154 |
negative regulation of membrane invagination(GO:1905154) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.2 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.1 |
0.3 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.1 |
0.7 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.3 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
0.3 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.1 |
0.5 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
1.2 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.1 |
0.3 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
0.6 |
GO:0006544 |
glycine metabolic process(GO:0006544) |
| 0.1 |
0.4 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.1 |
0.3 |
GO:0071435 |
potassium ion export(GO:0071435) |
| 0.1 |
0.3 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.2 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.1 |
0.3 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.1 |
0.3 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
0.6 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
| 0.1 |
0.3 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.1 |
1.2 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.1 |
0.6 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.7 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.1 |
0.6 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.3 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 |
0.5 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.1 |
0.4 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.1 |
0.2 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.1 |
0.1 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.1 |
0.2 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
0.5 |
GO:0014841 |
skeletal muscle satellite cell proliferation(GO:0014841) |
| 0.1 |
0.8 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
0.4 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.1 |
0.2 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.1 |
0.2 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 |
1.3 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
2.2 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.1 |
0.3 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.1 |
0.3 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
1.1 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.2 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
0.6 |
GO:1901844 |
regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.1 |
0.3 |
GO:0060872 |
semicircular canal development(GO:0060872) |
| 0.1 |
0.4 |
GO:0061684 |
chaperone-mediated autophagy(GO:0061684) |
| 0.1 |
0.5 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.4 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 0.1 |
0.3 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 |
0.5 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.1 |
0.4 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.7 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
1.2 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.2 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.1 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
0.8 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.1 |
0.5 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
0.2 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 |
0.2 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.5 |
GO:0045922 |
negative regulation of fatty acid metabolic process(GO:0045922) |
| 0.1 |
0.1 |
GO:0090335 |
regulation of brown fat cell differentiation(GO:0090335) |
| 0.1 |
0.5 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
| 0.1 |
0.7 |
GO:2000191 |
regulation of fatty acid transport(GO:2000191) |
| 0.1 |
1.1 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.1 |
0.1 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.1 |
0.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.1 |
0.3 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.1 |
0.2 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.1 |
0.2 |
GO:0042510 |
regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
| 0.1 |
0.3 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
0.2 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.1 |
0.2 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 |
1.0 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
3.0 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.1 |
0.3 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.1 |
0.6 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.1 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
| 0.1 |
0.5 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
2.0 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
0.1 |
GO:0033092 |
positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.1 |
1.0 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.6 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 |
0.2 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
0.1 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.1 |
1.0 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.1 |
0.4 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
0.1 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 |
0.1 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.1 |
0.6 |
GO:0009437 |
amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
| 0.1 |
0.7 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.6 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.1 |
0.4 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.1 |
0.6 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 |
0.4 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
0.3 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.1 |
0.1 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.1 |
0.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
0.5 |
GO:0030879 |
mammary gland development(GO:0030879) |
| 0.1 |
0.7 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.2 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.9 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.1 |
0.1 |
GO:1902065 |
response to L-glutamate(GO:1902065) |
| 0.1 |
0.9 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
0.3 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 |
0.6 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.1 |
0.9 |
GO:0098656 |
anion transmembrane transport(GO:0098656) |
| 0.1 |
0.3 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.1 |
0.5 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 |
0.5 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
0.6 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
0.2 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.1 |
0.5 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
0.3 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.7 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
0.1 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.1 |
1.4 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.1 |
0.2 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 |
0.5 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.8 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
0.1 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.1 |
0.2 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.1 |
GO:0003207 |
cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
| 0.1 |
0.3 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 |
0.2 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.1 |
0.3 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.1 |
0.4 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) |
| 0.1 |
0.5 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 |
0.1 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.1 |
0.1 |
GO:0035552 |
oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.1 |
1.4 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.1 |
0.4 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
0.1 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
0.5 |
GO:0042036 |
negative regulation of cytokine biosynthetic process(GO:0042036) |
| 0.1 |
0.1 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
0.4 |
GO:1903056 |
melanocyte migration(GO:0097324) regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.1 |
0.2 |
GO:0048524 |
positive regulation of viral process(GO:0048524) |
| 0.1 |
0.2 |
GO:0044110 |
growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
| 0.1 |
0.5 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 |
0.5 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.4 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 |
0.2 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.4 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.1 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.1 |
GO:0001911 |
negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
| 0.1 |
0.1 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.1 |
0.5 |
GO:0045909 |
positive regulation of vasodilation(GO:0045909) |
| 0.1 |
0.2 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
0.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.1 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.1 |
0.3 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
0.2 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 |
0.4 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.2 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.1 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.1 |
1.5 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
1.1 |
GO:0046033 |
AMP metabolic process(GO:0046033) |
| 0.1 |
0.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
0.3 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.1 |
0.1 |
GO:0031342 |
negative regulation of cell killing(GO:0031342) |
| 0.1 |
0.1 |
GO:0000966 |
RNA 5'-end processing(GO:0000966) |
| 0.1 |
0.2 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.2 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.1 |
0.3 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.1 |
0.1 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 |
0.1 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.1 |
0.6 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 |
0.1 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
0.2 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.1 |
0.2 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.1 |
0.1 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.1 |
0.1 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.1 |
1.0 |
GO:0006325 |
chromatin organization(GO:0006325) |
| 0.1 |
0.4 |
GO:0035437 |
maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 |
0.2 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.1 |
0.5 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.1 |
GO:0050951 |
sensory perception of temperature stimulus(GO:0050951) |
| 0.1 |
0.1 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
0.1 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.2 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.1 |
2.1 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.1 |
0.5 |
GO:2000780 |
negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
| 0.1 |
0.3 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 |
0.1 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.1 |
0.2 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.1 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 |
0.2 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 |
0.1 |
GO:0033233 |
regulation of protein sumoylation(GO:0033233) |
| 0.1 |
0.1 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.3 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 |
0.1 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.0 |
0.2 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.1 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 |
0.5 |
GO:0019363 |
pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.0 |
0.2 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.6 |
GO:0042098 |
T cell proliferation(GO:0042098) |
| 0.0 |
0.1 |
GO:0009074 |
aromatic amino acid family catabolic process(GO:0009074) |
| 0.0 |
0.7 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.0 |
0.0 |
GO:0044838 |
cell quiescence(GO:0044838) |
| 0.0 |
0.1 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.0 |
0.2 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.0 |
0.1 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.0 |
0.3 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.0 |
0.1 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.3 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.4 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.0 |
0.4 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.7 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.0 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
0.5 |
GO:0032760 |
positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
| 0.0 |
0.1 |
GO:0035587 |
adenosine receptor signaling pathway(GO:0001973) purinergic receptor signaling pathway(GO:0035587) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 0.0 |
0.1 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.0 |
0.2 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.0 |
0.6 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 |
0.1 |
GO:0048549 |
regulation of pinocytosis(GO:0048548) positive regulation of pinocytosis(GO:0048549) |
| 0.0 |
0.1 |
GO:1901534 |
positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.0 |
0.2 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 |
0.6 |
GO:0038061 |
NIK/NF-kappaB signaling(GO:0038061) |
| 0.0 |
0.1 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.0 |
0.5 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 |
0.3 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.0 |
0.3 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.0 |
0.1 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.0 |
0.1 |
GO:0003222 |
ventricular trabecula myocardium morphogenesis(GO:0003222) |
| 0.0 |
0.1 |
GO:0060768 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.0 |
0.3 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.4 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.0 |
0.2 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.0 |
0.2 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.1 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.0 |
0.1 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.0 |
0.4 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.0 |
0.3 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.2 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.0 |
0.5 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.0 |
0.3 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.0 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.0 |
0.1 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.0 |
0.2 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.1 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.0 |
0.1 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.0 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.0 |
0.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
1.1 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.0 |
0.0 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.0 |
1.0 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.1 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.0 |
0.3 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.0 |
0.1 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.0 |
0.4 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.0 |
0.2 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 |
0.0 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.0 |
0.1 |
GO:0090382 |
phagosome maturation(GO:0090382) |
| 0.0 |
0.3 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 |
0.3 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.2 |
GO:0030952 |
establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.0 |
0.9 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.0 |
0.1 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.0 |
0.4 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.4 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.0 |
0.2 |
GO:0032048 |
cardiolipin metabolic process(GO:0032048) |
| 0.0 |
0.1 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.0 |
0.1 |
GO:0002577 |
regulation of antigen processing and presentation(GO:0002577) |
| 0.0 |
0.0 |
GO:0010837 |
regulation of keratinocyte proliferation(GO:0010837) |
| 0.0 |
0.2 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.0 |
0.0 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 |
0.1 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.0 |
0.0 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.0 |
0.1 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.0 |
0.1 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.0 |
0.4 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.0 |
0.0 |
GO:2000036 |
regulation of stem cell population maintenance(GO:2000036) |
| 0.0 |
0.1 |
GO:0034139 |
regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.0 |
0.1 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.0 |
0.1 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.0 |
0.4 |
GO:0090004 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 |
0.2 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.0 |
0.2 |
GO:0060903 |
regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
| 0.0 |
0.3 |
GO:0010863 |
positive regulation of phospholipase C activity(GO:0010863) |
| 0.0 |
0.9 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.4 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.0 |
0.6 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.0 |
0.3 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 |
0.1 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.0 |
2.0 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.0 |
0.2 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.0 |
0.1 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.0 |
0.1 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.1 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.0 |
0.1 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.0 |
0.0 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.3 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.5 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
1.4 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.4 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.0 |
0.9 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.0 |
0.1 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
0.3 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.1 |
GO:0009414 |
response to water deprivation(GO:0009414) response to water(GO:0009415) |
| 0.0 |
0.2 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.3 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.0 |
0.1 |
GO:0006302 |
double-strand break repair(GO:0006302) |
| 0.0 |
0.1 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.0 |
0.1 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.0 |
0.3 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.3 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.0 |
0.2 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.0 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.0 |
0.1 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.0 |
0.4 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.1 |
GO:0046103 |
inosine biosynthetic process(GO:0046103) |
| 0.0 |
0.1 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.2 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.1 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.0 |
0.2 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.0 |
0.2 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.4 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.0 |
0.2 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.2 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.0 |
0.3 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.0 |
0.2 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.0 |
0.1 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 |
0.2 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.1 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.0 |
0.0 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.0 |
0.2 |
GO:0034644 |
cellular response to UV(GO:0034644) |
| 0.0 |
0.2 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.0 |
0.4 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.0 |
0.6 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.0 |
0.1 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.0 |
0.2 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.0 |
0.1 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 0.0 |
0.1 |
GO:0018022 |
peptidyl-lysine methylation(GO:0018022) |
| 0.0 |
0.2 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 |
0.1 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.0 |
0.2 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.0 |
1.5 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.1 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.0 |
0.1 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.4 |
GO:0003143 |
embryonic heart tube morphogenesis(GO:0003143) |
| 0.0 |
0.0 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.0 |
0.1 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.0 |
0.4 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.0 |
0.1 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 |
0.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 |
0.3 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.1 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.0 |
0.1 |
GO:1903078 |
positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.0 |
0.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.3 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.1 |
GO:0033151 |
V(D)J recombination(GO:0033151) |
| 0.0 |
0.1 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.0 |
0.0 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.0 |
0.2 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 |
0.1 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.0 |
0.1 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.0 |
0.1 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.0 |
0.3 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.2 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 |
0.3 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 |
0.1 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.0 |
0.1 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.0 |
0.1 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.0 |
0.1 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.1 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.3 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.0 |
0.1 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.0 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.0 |
0.6 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
0.0 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.0 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.0 |
0.3 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.0 |
0.3 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.3 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.0 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.0 |
0.1 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.0 |
0.2 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
| 0.0 |
0.0 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.0 |
0.0 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.0 |
0.1 |
GO:0010820 |
regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 0.0 |
0.0 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.0 |
0.1 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.0 |
0.1 |
GO:0002011 |
morphogenesis of an epithelial sheet(GO:0002011) |
| 0.0 |
0.0 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.0 |
0.6 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.2 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.0 |
0.4 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.1 |
GO:0071267 |
amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 0.0 |
0.1 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.0 |
0.0 |
GO:0044854 |
plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
| 0.0 |
0.1 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.0 |
0.1 |
GO:1902044 |
regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
| 0.0 |
0.4 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.0 |
0.1 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.0 |
0.1 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 |
0.0 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 |
0.4 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.1 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.0 |
0.1 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.0 |
0.5 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.0 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.0 |
0.2 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.0 |
1.1 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.0 |
0.1 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.4 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.0 |
0.0 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.0 |
0.0 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.0 |
0.0 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.0 |
0.4 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.3 |
GO:0045724 |
positive regulation of cilium assembly(GO:0045724) |
| 0.0 |
0.1 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 |
0.2 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.0 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.0 |
0.3 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 |
0.3 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.0 |
0.1 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 |
0.0 |
GO:0010518 |
positive regulation of phospholipase activity(GO:0010518) |
| 0.0 |
0.2 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.0 |
0.1 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.0 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.0 |
0.3 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) regulation of ERBB signaling pathway(GO:1901184) |
| 0.0 |
0.0 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.0 |
0.0 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.0 |
0.4 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
0.1 |
GO:0002066 |
columnar/cuboidal epithelial cell development(GO:0002066) |
| 0.0 |
0.0 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.0 |
0.1 |
GO:0060147 |
regulation of posttranscriptional gene silencing(GO:0060147) regulation of gene silencing by RNA(GO:0060966) |
| 0.0 |
0.0 |
GO:0051497 |
negative regulation of stress fiber assembly(GO:0051497) |
| 0.0 |
0.1 |
GO:0097006 |
regulation of plasma lipoprotein particle levels(GO:0097006) |
| 0.0 |
0.0 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.0 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.1 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.0 |
0.0 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.0 |
0.0 |
GO:0060546 |
negative regulation of necroptotic process(GO:0060546) |
| 0.0 |
0.2 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.0 |
0.0 |
GO:0002295 |
T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
| 0.0 |
0.5 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.0 |
0.2 |
GO:0043507 |
positive regulation of JUN kinase activity(GO:0043507) |
| 0.0 |
0.1 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.0 |
0.0 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.0 |
0.0 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.0 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.0 |
0.0 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.0 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.0 |
0.1 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.0 |
GO:0050926 |
regulation of positive chemotaxis(GO:0050926) positive regulation of positive chemotaxis(GO:0050927) |
| 0.0 |
0.1 |
GO:0061036 |
positive regulation of cartilage development(GO:0061036) |
| 0.0 |
0.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.2 |
GO:0007043 |
cell-cell junction assembly(GO:0007043) |
| 0.0 |
0.1 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.0 |
0.0 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.0 |
0.0 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.0 |
0.0 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.0 |
0.0 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
